Vitura Health Limited

VIT.AX

Drug Manufacturers - Specialty & Generic · Healthcare

Price

A$0.03

+0.00 (+4.17%)

Market Cap

A$16.6M

Exchange

Australian Securities Exchange

Winston Score

Winston is serious

Below-average fundamentals — multiple weak pillars.

Data as of Aug 9, 2026 · filings through Dec 31, 2025

Share count rising — dilution

+51.8% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 401.7M (2021) → 609.9M (2025)

Vitura Health Limited is an Australian healthcare company focused on medicinal cannabis. It connects patients with doctors and dispensaries through its digital platform, Canview, which is one of Australia's largest online marketplaces for prescribed cannabis products. The company serves patients seeking legal medicinal cannabis prescriptions and the pharmacies and clinics that fulfill them.

Vitura makes money by taking a margin on cannabis product sales distributed through its platform, acting as a middleman between suppliers and patients. It operates entirely in Australia, where medicinal cannabis has been legal since 2016 but the market is still maturing. The company is small, with a market cap near zero and thin operating margins around 1.8%, reflecting a competitive and fragmented industry. The key growth driver is continued expansion of Australia's medicinal cannabis patient base, but the main risk is margin pressure as more suppliers and platforms enter the market, squeezing Vitura's already narrow cut of each transaction.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-4.0% YoY

YoY Growth Rate

Revenue declining

EPS Growth

+525.0% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

45.5%ownership

Insiders own a meaningful stake in the company

Cash Position

Cash flow positive

$11M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Revenue declining

Vitura Health Limited's revenue is actually shrinking. In a growth stock, that removes the core investment thesis. The low Winston Score here may be warranted — unless there's a turnaround story.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

4.4%

Thin — 4.4% gross margin

Operating Margin

-0.1%

Losing money on operations — -0.1%

ROCE

-0.1%

Weak — -0.1% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

+2.1%

Nearly flat sales (+2.1% YoY)

EPS YoY

-63.6%

Earnings shrinking (-63.6% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

EPS Consistency

4/8 quarters

Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

188%

Turns 188% of profit into real cash

FCF Margin

1.1%

Thin free cash flow (1.1%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

0.34

Conservative — low debt load (0.34)

Interest Cover

1.78x

Dangerous — barely covers interest (1.8x)

Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

20.8x

Growth-priced — P/E 20.8

P/E above the market average. People are paying up for expected growth.

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend Yield

7.69%

Healthy income — 7.69% yield

Yield above 6% — often a flag the market is pricing in a cut.

Dividend Growth

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial